Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that must be diagnosed early to increase drug therapy efficacy. No early definitive diagnostic tool, however, is currently available, thus prompting for the identification of biomarkers of the disease. Isoprostanes (iPs) are prostaglandin-related free radical oxidation products of polyunsaturated fatty acids (PUFA) that are produced under oxidative stress conditions that occur, for instance, in the brain of AD sufferers. iPs are stable lipids known to partition in bodily fluids and are thus interesting potential biomarkers of AD. However, resolution of iPs by reverse phase HPLC is complicated by the existence of multiple regioisomers and enantiomers. Consequently, we have developed two normal phase chiral approaches for the detailed analysis of the F2-iP class of isoprostanes. First, normal phase chiral LC-MS/MS permitted the identification and quantification of four types of F2- iPs in urine samples from control, mild cognitive impairment (MCI) patients and severe AD sufferers. Second, given its suitability for non-polar compounds analysis and chiral separations, supercritical fluid chromatography (SFC) was investigated as an alternative approach. SFC-MS/MS enabled the identification of regioisomers and enantiomers of F2-iPs. Identification of analytes was undertaken by MRM monitoring of diagnostic transitions while the chiral chromatography allowed for the resolution of enantiomers within types. F-iPs could be reproducibly identified and quantified.
Keywords: Supercritical fluid chromatography, SFC, mass spectrometry, chiral separation, isoprostanes, Alzheimer’s disease.
Current Analytical Chemistry
Title:Investigation of Isoprostanes as Potential Biomarkers for Alzheimer's Disease Using Chiral LC-MS/MS and SFC-MS/MS
Volume: 10 Issue: 1
Author(s): Victoria Goss, Amaury Cazenave-Gassiot, Ashley Pringle and Anthony Postle
Affiliation:
Keywords: Supercritical fluid chromatography, SFC, mass spectrometry, chiral separation, isoprostanes, Alzheimer’s disease.
Abstract: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that must be diagnosed early to increase drug therapy efficacy. No early definitive diagnostic tool, however, is currently available, thus prompting for the identification of biomarkers of the disease. Isoprostanes (iPs) are prostaglandin-related free radical oxidation products of polyunsaturated fatty acids (PUFA) that are produced under oxidative stress conditions that occur, for instance, in the brain of AD sufferers. iPs are stable lipids known to partition in bodily fluids and are thus interesting potential biomarkers of AD. However, resolution of iPs by reverse phase HPLC is complicated by the existence of multiple regioisomers and enantiomers. Consequently, we have developed two normal phase chiral approaches for the detailed analysis of the F2-iP class of isoprostanes. First, normal phase chiral LC-MS/MS permitted the identification and quantification of four types of F2- iPs in urine samples from control, mild cognitive impairment (MCI) patients and severe AD sufferers. Second, given its suitability for non-polar compounds analysis and chiral separations, supercritical fluid chromatography (SFC) was investigated as an alternative approach. SFC-MS/MS enabled the identification of regioisomers and enantiomers of F2-iPs. Identification of analytes was undertaken by MRM monitoring of diagnostic transitions while the chiral chromatography allowed for the resolution of enantiomers within types. F-iPs could be reproducibly identified and quantified.
Export Options
About this article
Cite this article as:
Goss Victoria, Cazenave-Gassiot Amaury, Pringle Ashley and Postle Anthony, Investigation of Isoprostanes as Potential Biomarkers for Alzheimer's Disease Using Chiral LC-MS/MS and SFC-MS/MS, Current Analytical Chemistry 2014; 10 (1) . https://dx.doi.org/10.2174/1573411011410010010
DOI https://dx.doi.org/10.2174/1573411011410010010 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
Call for Papers in Thematic Issues
Advancements in biomedicine, corrosion inhibition/monitoring, and lubrication of carbon dots
Carbon dots, a class of carbon-based nanomaterials, have garnered substantial interest in various scientific and engineering fields due to their unique properties, including excellent optical properties, outstanding biocompatibility, easy preparation, good dispersity, ultrasmall size, low toxicity and environmental friendliness. This special issue of Current Analytical Chemistry aims to showcase cutting-edge ...read more
Analytical methods for environmental and food analysis
In recent years, the study of the chemical composition of food and the environment depends on analytical methods in order to acquire information about the chemical composition, processing, quality control and contamination of soil, water, air, plants and foods, aspects very important for food safety and environmental quality control. There ...read more
Applications of artificial intelligence in chemical analysis
Artificial intelligence (AI) has demonstrated its versatility in almost all scientific fields, especially analytical chemistry, which is leading the way in the integration of AI. According to Chemical Abstract Services, one of the major disciplines contributing to AI-related publications and patents is analytical chemistry. That?s because techniques such as deep ...read more
Bioanalytical and Biosensor Technologies for Target Molecules
Bioanalytical and biosensor technologies constitute the core of detecting and sensing diverse molecules within living organisms, encompassing proteins, DNA, small molecular metabolites, and beyond. These molecules assume pivotal roles in biological processes, rendering their analysis and sensing indispensable for comprehending biological phenomena and unraveling disease mechanisms. In the current landscape ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mediterranean Diet and Dementia of the Alzheimer Type
Current Aging Science <i>In Vivo/Ex Vivo</i> EPR Investigation of the Brain Redox Status and Blood-Brain Barrier Integrity in the 5xFAD Mouse Model of Alzheimer's Disease
Current Alzheimer Research Pharmacological Targeting of the Hsp70 Chaperone
Current Topics in Medicinal Chemistry Berberine Nanoencapsulation Attenuates Hallmarks of Scoplomine Induced Alzheimer's-Like Disease in Rats
Current Reviews in Clinical and Experimental Pharmacology W-F Substitutions in Apomyoglobin Increase the Local Flexibility of the N-terminal Region Causing Amyloid Aggregation: A H/D Exchange Study
Protein & Peptide Letters Role of Nitric Oxide Signaling Pathways in Brain Injuries
Current Chemical Biology Applying Auto-Regressive Model’s Yule-Walker Approach to Amyotrophic Lateral Sclerosis (ALS) patients’ Data
Current Medical Imaging Modulation of Mitochondrial Permeability Transition in Ischemia-Reperfusion Injury of the Heart. Advantages and Limitations
Current Medicinal Chemistry Phylogenetic and Functional Classification of ATP-Binding Cassette (ABC) Systems
Current Protein & Peptide Science Amyotrophic Lateral Sclerosis and Excitotoxicity: From Pathological Mechanism to Therapeutic Target
CNS & Neurological Disorders - Drug Targets Pharmacological Aspects of (-)-Deprenyl
Current Medicinal Chemistry An Overview and Therapeutic Promise of Nutraceuticals Against Sports-Related Brain Injury
Current Molecular Pharmacology Neurodegeneration and the Heat Shock Protein 70 Machinery: Implications for Therapeutic Development
Current Topics in Medicinal Chemistry Mitochondrial Fusion and Fission Proteins Expression Dynamically Change in a Murine Model of Amyotrophic Lateral Sclerosis
Current Neurovascular Research Detrimental Effects of Apolipoprotein E4: Potential Therapeutic Targets in Alzheimers Disease
Current Alzheimer Research NADPH Oxidase and Neurodegeneration
Current Neuropharmacology Ghrelin Receptor Signaling: A Promising Therapeutic Target for Metabolic Syndrome and Cognitive Dysfunction
CNS & Neurological Disorders - Drug Targets Clinical Applications of Creatine Supplementation on Paediatrics
Current Pharmaceutical Biotechnology Nanoparticles as Alternative Strategies for Drug Delivery to the Alzheimer Brain: Electron Microscopy Ultrastructural Analysis
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Neuroprotective Effects of Li - It is Elementary)
Current Alzheimer Research